Veracyte reported $-14461000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agenus AGEN:US $ -48.32M 17.19M
Agilent A:US $ 274M 9M
Anika Therapeutics ANIK:US $ -2.93M 2.86M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Biocept BIOC:US $ -2.77M 0.2M
Bruker BRKR:US $ 61.6M 14.1M
Exact Sciences EXAS:US $ -180.94M 39.67M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Illumina ILMN:US $ 86M 26M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -19.25M 5.78M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Laboratory Of America LH:US $ 491.6M 61.4M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Myriad Genetics MYGN:US $ -20.5M 12.9M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.8M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Siemens SIE:GR € 1034M 609M
Sonic Healthcare SHL:AU $ 827.66M 190.26M
Thermo Fisher Scientific TMO:US $ 2215M 557M
Veracyte VCYT:US $ -14.46M 3.93M
Waters WAT:US $ 159.83M 56.41M